Literature DB >> 16701545

Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms.

V Rousseau1, J P Lepargneur, C Roques, M Remaud-Simeon, F Paul.   

Abstract

The purpose of this study was to select endogenous human vaginal lactobacilli strains on the basis of the main probiotic properties observed in the vaginal environment in order to use them for the evaluation of the potential prebiotic properties of oligosaccharides. From vaginal samples of 50 women with a normal flora, 17 lactobacilli strains were first isolated because of their high level of hydrogen peroxide production. Then six strains were selected mainly for their ability (i) to adhere to vaginal cells, (ii) to produce compounds in sufficient amount, such as lactic acid, having an inhibitory action on pathogens, and less importantly, (iii) to demonstrate arginine deiminase activity. These six strains were found to belong to three distinct species: Lactobacillus crispatus, L. jensenii and L. vaginalis. One strain of each species was chosen as a potential vaginal probiotic strain with regard to our criteria. These three strains were then used to evaluate the prebiotic properties of different oligosaccharide series: two fructooligosaccharide series (FOS Actilight and FOS Raftilose) and two glucooligosaccharide series varying by their osidic linkages (alpha-1,6/alpha-1,4 GOS and alpha-1,2/alpha-1,6/alpha-1,4 GOS). The test was based on the ability of the oligosaccharides to promote the growth of the three beneficial strains selected but not of pathogenic microorganisms often encountered in urogenital infections such as Candida albicans, Escherichia coli and Gardnerella vaginalis. Oligosaccharide hydrolysis was followed by HPLC analysis. This revealed that two oligosaccharide series (FOS Actilight DP3 and all alpha-1,6/alpha-1,4 GOS DP > or = 4) were used only by the lactobacilli strains, the pathogenic microorganisms being unable to metabolise them. The selected lactobacilli and oligosaccharides are good candidates for incorporation in a formula to prevent vaginal infections.

Entities:  

Year:  2005        PMID: 16701545     DOI: 10.1016/j.anaerobe.2004.12.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  16 in total

1.  Antibacterial treatment of bacterial vaginosis: current and emerging therapies.

Authors:  Jean-Pierre Menard
Journal:  Int J Womens Health       Date:  2011-08-23

Review 2.  The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?

Authors:  Anita Mitra; David A MacIntyre; Julian R Marchesi; Yun S Lee; Phillip R Bennett; Maria Kyrgiou
Journal:  Microbiome       Date:  2016-11-01       Impact factor: 14.650

3.  Technological and Probiotic Traits of the Lactobacilli Isolated From Vaginal Tract of the Healthy Women for Probiotic Use.

Authors:  Hamida Bouridane; Mohamed Sifour; Tayeb Idoui; Lejeune Annick; Philip Thonard
Journal:  Iran J Biotechnol       Date:  2016-09       Impact factor: 1.671

4.  Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota.

Authors:  Stephanie L Collins; Amy McMillan; Shannon Seney; Charlotte van der Veer; Remco Kort; Mark W Sumarah; Gregor Reid
Journal:  Appl Environ Microbiol       Date:  2018-02-14       Impact factor: 4.792

Review 5.  The Influences of Soybean Agglutinin and Functional Oligosaccharides on the Intestinal Tract of Monogastric Animals.

Authors:  Li Pan; Mohammed Hamdy Farouk; Guixin Qin; Yuan Zhao; Nan Bao
Journal:  Int J Mol Sci       Date:  2018-02-12       Impact factor: 5.923

6.  Study of the Vaginal Microbiota in Healthy Women of Reproductive Age.

Authors:  Melanie C Alonzo Martínez; Eduardo Cazorla; Esther Cánovas; Juan F Martínez-Blanch; Empar Chenoll; Eric Climent; Vicente Navarro-López
Journal:  Microorganisms       Date:  2021-05-15

Review 7.  The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis.

Authors:  Silke Baldewijns; Mart Sillen; Ilse Palmans; Paul Vandecruys; Patrick Van Dijck; Liesbeth Demuyser
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640

8.  Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions.

Authors:  Samir Jawhara; Khalid Habib; François Maggiotto; Georges Pignede; Pascal Vandekerckove; Emmanuel Maes; Laurent Dubuquoy; Thierry Fontaine; Yann Guerardel; Daniel Poulain
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

9.  Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: a randomized double-blind study.

Authors:  Isabelle Coste; Philippe Judlin; Jean-Pierre Lepargneur; Sami Bou-Antoun
Journal:  Obstet Gynecol Int       Date:  2012-12-18

Review 10.  Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions.

Authors:  Daniela Machado; Joana Castro; Ana Palmeira-de-Oliveira; José Martinez-de-Oliveira; Nuno Cerca
Journal:  Front Microbiol       Date:  2016-01-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.